|
MechanismGABAA receptor agonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 2001 |
100 Clinical Results associated with Orpha-Devel Handels Und Vertriebs Gmbh
0 Patents (Medical) associated with Orpha-Devel Handels Und Vertriebs Gmbh
100 Deals associated with Orpha-Devel Handels Und Vertriebs Gmbh
100 Translational Medicine associated with Orpha-Devel Handels Und Vertriebs Gmbh